• 1. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 2. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 3. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 4. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 5. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

(R)-3-(m-Tolyl)-β-alanine (CAS No. 748128-33-8): A Comprehensive Overview

(R)-3-(m-Tolyl)-β-alanine (CAS No. 748128-33-8) is a chiral β-amino acid that has garnered significant attention in recent years due to its unique structural properties and potential applications in various fields, including medicinal chemistry, pharmaceuticals, and materials science. This compound is characterized by its chiral center and the presence of a tolyl group, which imparts specific stereochemical and electronic properties that make it a valuable building block in the synthesis of complex molecules.

The chiral nature of (R)-3-(m-Tolyl)-β-alanine is particularly important in the context of drug development, where enantiomeric purity is crucial for ensuring the efficacy and safety of therapeutic agents. The ability to synthesize and isolate specific enantiomers has led to significant advancements in the design of chiral drugs, which can exhibit distinct pharmacological profiles compared to their racemic counterparts. Recent studies have highlighted the role of β-amino acids, such as (R)-3-(m-Tolyl)-β-alanine, in the development of novel peptidomimetics and protein mimics, which have shown promise in treating a variety of diseases.

In the realm of medicinal chemistry, (R)-3-(m-Tolyl)-β-alanine has been explored as a key intermediate in the synthesis of bioactive compounds. Its unique structure allows for the introduction of functional groups that can enhance the binding affinity and selectivity of target molecules. For instance, researchers have utilized (R)-3-(m-Tolyl)-β-alanine to develop inhibitors of enzymes involved in metabolic pathways, such as kinases and proteases. These inhibitors have shown potential in preclinical studies for treating conditions like cancer, neurodegenerative diseases, and inflammatory disorders.

The pharmaceutical industry has also shown interest in (R)-3-(m-Tolyl)-β-alanine due to its potential as a prodrug precursor. Prodrugs are biologically inactive compounds that are converted into active drugs through metabolic processes within the body. By incorporating (R)-3-(m-Tolyl)-β-alanine into prodrug designs, scientists aim to improve the solubility, stability, and bioavailability of therapeutic agents. This approach has been particularly useful in addressing challenges associated with oral drug delivery and enhancing patient compliance.

Beyond its applications in drug development, (R)-3-(m-Tolyl)-β-alanine has found utility in materials science. The chiral structure and functional groups present in this compound make it an attractive candidate for the synthesis of chiral materials with unique optical and electronic properties. Recent research has focused on using β-amino acids like (R)-3-(m-Tolyl)-β-alanine to create chiral nanomaterials and polymers with applications in sensors, catalysts, and optoelectronic devices.

The synthesis of (R)-3-(m-Tolyl)-β-alanine typically involves multistep procedures that ensure high enantiomeric purity. Common synthetic routes include asymmetric catalysis, enzymatic resolution, and chiral auxiliaries. Advances in these methodologies have led to more efficient and scalable processes for producing this compound on both laboratory and industrial scales. The ability to produce large quantities of high-purity (R)-3-(m-Tolyl)-β-alanine is essential for meeting the growing demand from various industries.

In conclusion, (R)-3-(m-Tolyl)-β-alanine (CAS No. 748128-33-8) is a versatile compound with a wide range of applications in medicinal chemistry, pharmaceuticals, and materials science. Its unique structural features and chiral nature make it an invaluable building block for the development of novel therapeutic agents and advanced materials. Ongoing research continues to uncover new possibilities for this compound, further solidifying its importance in modern scientific endeavors.

• 40856-44-8((3S)-3-amino-3-phenylpropanoic acid)
• 83649-47-2((S)-3-Phenyl-b-alanine Hydrochloride)
• 68208-18-4(3-Amino-3-(4-methylphenyl)propanoic Acid)
• 479065-00-4(H-b-Phe(4-Me)-OH)
• 83649-48-3((R)-3-Amino-3-phenylpropanoic acid hydrochloride)
• 3646-50-2(DL-3-Amino-3-phenylpropionic acid)
• 13921-90-9((βR)-β-Aminobenzenepropanoic Acid)
• 614-19-7(DL-β-Phenylalanine)
• 117391-52-3(3-Amino-3-(4-ethylphenyl)propanoic acid)
• 250374-96-0(Benzenepropanoic acid, b-amino-4-butyl-)